Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla - PubMed (original) (raw)
Clinical Trial
Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla
Saman Nazarian et al. Circulation. 2006.
Abstract
Background: Magnetic resonance imaging (MRI) is an important diagnostic modality currently unavailable for millions of patients because of the presence of implantable cardiac devices. We sought to evaluate the diagnostic utility and safety of noncardiac and cardiac MRI at 1.5T using a protocol that incorporates device selection and programming and limits the estimated specific absorption rate of MRI sequences.
Methods and results: Patients with no imaging alternative and with devices shown to be MRI safe by in vitro phantom and in vivo animal testing were enrolled. Of 55 patients who underwent 68 MRI studies, 31 had a pacemaker, and 24 had an implantable defibrillator. Pacing mode was changed to "asynchronous" for pacemaker-dependent patients and to "demand" for others. Magnet response and tachyarrhythmia functions were disabled. Blood pressure, ECG, oximetry, and symptoms were monitored. Efforts were made to limit the system-estimated whole-body average specific absorption rate to 2.0 W/kg (successful in >99% of sequences) while maintaining the diagnostic capability of MRI. No episodes of inappropriate inhibition or activation of pacing were observed. There were no significant differences between baseline and immediate or long-term (median 99 days after MRI) sensing amplitudes, lead impedances, or pacing thresholds. Diagnostic questions were answered in 100% of nonthoracic and 93% of thoracic studies. Clinical findings included diagnosis of vascular abnormalities (9 patients), diagnosis or staging of malignancy (9 patients), and assessment of cardiac viability (13 patients).
Conclusions: Given appropriate precautions, noncardiac and cardiac MRI can potentially be safely performed in patients with selected implantable pacemaker and defibrillator systems.
Figures
Figure 1
Safety protocol for imaging of patients with permanent pacemaker and ICD systems. Devices listed have previously undergone satisfactory in vitro phantom and in vivo animal testing.
Figure 2
Typical susceptibility artifacts with (A) inversion recovery prepared gradient echo and (B) steady-state free-precession sequences. In A, the region of anterolateral hyperenhancement is due to artifact compared with subendocardial hyperenhancement in the septum, which likely represents prior infarction.
Figure 3
Cardiac MRI with minimal artifact using (A) time-of-flight sequence to demonstrate the anatomy of congenitally corrected transposition of great vessels in a patient with a permanent pacemaker and (B) steady-state free-precession sequence to assess coronary sinus patency in a patient with an implantable defibrillator.
Figure 4
Comparison of computed tomography versus diffusion-weighted MRI images of the brain in a pacemaker-dependent patient who presented with new-onset loss of balance. Although the imaging planes are different due to computed tomography versus MRI technique, both sets of images span similar areas of the cerebellum and occipital cortex. No abnormalities were noted on computed tomography, whereas MRI readily identified infarcts involving the cerebellum and occipital cortex (arrows).
Comment in
- Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients.
Faris OP, Shein M. Faris OP, et al. Circulation. 2006 Sep 19;114(12):1232-3. doi: 10.1161/CIRCULATIONAHA.106.647800. Circulation. 2006. PMID: 16982951 No abstract available.
Similar articles
- A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI).
Burke PT, Ghanbari H, Alexander PB, Shaw MK, Daccarett M, Machado C. Burke PT, et al. J Interv Card Electrophysiol. 2010 Jun;28(1):59-66. doi: 10.1007/s10840-009-9463-y. Epub 2010 Jan 29. J Interv Card Electrophysiol. 2010. PMID: 20111895 - A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices.
Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR. Nazarian S, et al. Ann Intern Med. 2011 Oct 4;155(7):415-24. doi: 10.7326/0003-4819-155-7-201110040-00004. Ann Intern Med. 2011. PMID: 21969340 Free PMC article. Clinical Trial. - The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices.
Dandamudi S, Collins JD, Carr JC, Mongkolwat P, Rahsepar AA, Tomson TT, Verma N, Arora R, Chicos AB, Kim SS, Lin AC, Passman RS, Knight BP. Dandamudi S, et al. Acad Radiol. 2016 Dec;23(12):1498-1505. doi: 10.1016/j.acra.2016.08.016. Epub 2016 Oct 4. Acad Radiol. 2016. PMID: 27717762 - Not all pacemakers are created equal: MRI conditional pacemaker and lead technology.
Ahmed FZ, Morris GM, Allen S, Khattar R, Mamas M, Zaidi A. Ahmed FZ, et al. J Cardiovasc Electrophysiol. 2013 Sep;24(9):1059-65. doi: 10.1111/jce.12238. J Cardiovasc Electrophysiol. 2013. PMID: 24016320 Review. - [Magnetic resonance imaging in patients with pacemakers and implantable cardioverter-defibrillators: a systematic review].
Martins RP, Baruteau AE, Treguer F, Césari O, Carsin-Nicol B, Langella B, Leclercq C, Daubert JC, Mabo P. Martins RP, et al. Ann Cardiol Angeiol (Paris). 2010 Aug;59(4):221-8. doi: 10.1016/j.ancard.2009.04.003. Epub 2009 May 14. Ann Cardiol Angeiol (Paris). 2010. PMID: 19962691 Review. French.
Cited by
- Magnetic resonance imaging conditional pacemakers: rationale, development and future directions.
Cronin EM, Wilkoff BL. Cronin EM, et al. Indian Pacing Electrophysiol J. 2012 Sep;12(5):204-12. doi: 10.1016/s0972-6292(16)30543-5. Epub 2012 Sep 1. Indian Pacing Electrophysiol J. 2012. PMID: 23071382 Free PMC article. - Practical applications of cardiovascular magnetic resonance.
Alpendurada F, Wong J, Pennell DJ. Alpendurada F, et al. Heart Asia. 2009 Jan 1;1(1):31-7. doi: 10.1136/ha.2009.000323. eCollection 2009. Heart Asia. 2009. PMID: 27325923 Free PMC article. Review. - Making MRI available for patients with cardiac implantable electronic devices: growing need and barriers to change.
Bhuva AN, Moralee R, Moon JC, Manisty CH. Bhuva AN, et al. Eur Radiol. 2020 Mar;30(3):1378-1384. doi: 10.1007/s00330-019-06449-5. Epub 2019 Nov 27. Eur Radiol. 2020. PMID: 31776746 Free PMC article. Review. - Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies.
Nazarian S, Kolandaivelu A, Zviman MM, Meininger GR, Kato R, Susil RC, Roguin A, Dickfeld TL, Ashikaga H, Calkins H, Berger RD, Bluemke DA, Lardo AC, Halperin HR. Nazarian S, et al. Circulation. 2008 Jul 15;118(3):223-9. doi: 10.1161/CIRCULATIONAHA.107.742452. Epub 2008 Jun 23. Circulation. 2008. PMID: 18574048 Free PMC article. - MR fluoroscopy in vascular and cardiac interventions (review).
Saeed M, Hetts SW, English J, Wilson M. Saeed M, et al. Int J Cardiovasc Imaging. 2012 Jan;28(1):117-37. doi: 10.1007/s10554-010-9774-1. Epub 2011 Feb 26. Int J Cardiovasc Imaging. 2012. PMID: 21359519 Free PMC article. Review.
References
- Quint DJ. Indications for emergent MRI of the central nervous system. JAMA. 2000;283:853–855. - PubMed
- Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004;25:1940 –1965. - PubMed
- Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004;43:1315–1324. - PubMed
- Essebag V, Eisenberg MJ. Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness. Card Electrophysiol Rev. 2003;7:43–48. - PubMed
- Brown DW, Croft JB, Giles WH, Anda RF, Mensah GA. Epidemiology of pacemaker procedures among Medicare enrollees in 1990, 1995, and 2000. Am J Cardiol. 2005;95:409–411. - PubMed
Publication types
MeSH terms
Grants and funding
- R01-HL64795/HL/NHLBI NIH HHS/United States
- R01 HL064795/HL/NHLBI NIH HHS/United States
- K24 HL004194/HL/NHLBI NIH HHS/United States
- K24-HL04194/HL/NHLBI NIH HHS/United States
- R01 HL064795-07/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical